Researchers report that an experimental drug first developed to treat kidney disease prolongs survival and improves muscle function in mice genetically engineered to develop a severe form of Duchenne muscular dystrophy (DMD).
Click here for original story, Blocking an ion channel improves muscle function and survival in mice with severe Duchenne muscular dystrophy
Source: ScienceDaily